Comparison of cefprozil and cefaclor for treatment of acute urinary tract infections in women.
Author(s): Iravani A
Affiliation(s): Pediatric Nephrology, College of Medicine, University of Florida, Gainesville 32610-0296.
Publication date & source: 1991-09, Antimicrob Agents Chemother., 35(9):1940-2.
Publication type: Clinical Trial; Controlled Clinical Trial
A total of 108 college women with acute urinary tract infections were treated for 10 days with either 500 mg of cefprozil (BMY-28100-03-800) once a day (n = 72) or 250 mg of cefaclor three times a day (n = 36). Clinical and bacterial cure rates at 1 week posttherapy were 94 and 93%, respectively, for the cefprozil group and 94 and 94%, respectively, for the cefaclor group (P, not significant). Both cefprozil and cefaclor were safe and effective.
|